A proposal for staging COVID?19 coagulopathy #MMPMID32685880
Thachil J; Cushman M; Srivastava A
Res Pract Thromb Haemost 2020[Jul]; 4 (5): 731-6 PMID32685880show ga
Coronavirus disease 2019 (COVID?19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID?19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.